Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rangering i aksjer #41
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aksjekurs
$459.10
Sist synkronisert: 2026-09-11
Markedsverdi
$359.91B
Endring (1 dag)
0.11%
Endring (1 år)
30.72%
Land
CH
Handel Roche Holding AG (RO)

Kategori

Inntekter for Roche Holding AG (RO)
Inntekter i Dec 2025 TTM: $21.39B
Ifølge Roche Holding AG sine nyeste økonomiske rapporter er selskapets nåværende resultat $21.39B. I 2024 hadde selskapet et resultat på $13.06B, en nedgang sammenlignet med resultatet i 2023, som var $16.74B. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Roche Holding AG fra 2000 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$33.59B 57.07%
US
$25.20B 17.80%
US
$8.70B -59.33%
US
$5.95B -72.19%
US
$16.38B -23.42%
CH